A phase Ib dose-escalation study of binimetinib (MEK162) in combination with weekly paclitaxel in patients with platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer Meeting Abstract


Authors: Grisham, R. N.; Gordon, M. S.; Harb, W. A.; Aghajanian, C.; McMeekin, D. S.; McKinley, K.; Anderson, L. R.; Chavira, R.; Christy-Bittel, J.; Barrett, E.; Moore, K. N.
Abstract Title: A phase Ib dose-escalation study of binimetinib (MEK162) in combination with weekly paclitaxel in patients with platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer
Meeting Title: 2015 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036901175
PROVIDER: wos
Notes: Meeting Abstract: 5516 -- Source: Wos
MSK Authors
  1. Rachel Nicole Grisham
    34 Grisham